AI
ONC

Atria Investments’s BeOne Medicines Ltd ONC Stock Holding History

Atria Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$315K Sell
1,060
-6
-0.6% -$1.94K ﹤0.01% 1726
2025
Q4 		$324K Sell
1,066
-349
-25% -$114K ﹤0.01% 1702
2025
Q3 		$482K Sell
1,415
-41
-3% -$12.4K 0.01% 1432
2025
Q2 		$352K Sell
1,456
-51
-3% -$12.5K ﹤0.01% 1615
2025
Q1 		$410K Sell
1,507
-387
-20% -$90.5K 0.01% 1459
2024
Q4 		$350K Sell
1,894
-33
-2% -$6.74K ﹤0.01% 1509
2024
Q3 		$433K Sell
1,927
-647
-25% -$116K 0.01% 1401
2024
Q2 		$367K Buy
+2,574
New +$397K ﹤0.01% 1469
2021
Q1 		– Sell
-12,733
Closed -$3.29M – 755
2020
Q4 		$3.29M Buy
+12,733
New +$3.51M 0.08% 274

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return